Document is current
Any future updates will be listed below
-
Authors
Park, Tae Hyun https://orcid.org/0000-0003-3783-7691
Yoon, Chan
Park, Jae Hyeon
Lee, Sanghee
Choi, Chi-hyun https://orcid.org/0000-0003-2120-1111
Chang, Chong Bum
Kim, Jin Goo
-
Funding
Funding for this research was provided by:
Ministry of Health & Welfare, Republic of Korea (RS-2023-KH142023)
- License Information
-
More Information
Article History
Received: 16 November 2024
Accepted: 3 August 2025
First Online: 1 September 2025
Declarations
:
: Ethical approval was granted by the following IRBs: Institutional Review Board, The Catholic University of Korea, Seoul St. Mary’s Hospital (No. KC24DDDS0561, approval date: 25th October 2024), Institutional Review Board, Kyung Hee University Hospital at Gandong (KHNMC 2024–03035, 8th April 2024), Seoul National University Bundang Hospital Institutional Review Board (E-2409–924-402, 22th August 2024), Seoul Metropolitan Government-Seoul National University Boramae Medical Center Institutional Review Board (30–2024-32, 20th May 2024), Institutional Review Board, MyongJi Hospital (2024–08-018, 28th August 2024), Inha University Hospital Institutional Review Board (INHAUH 2024–03-016, 24th May 2024), Asan Medical Center Institutional Review Board (2024–0762, 13th June 2024), Chung-Ang University Hospital Institutional Review Board (2403–005-592, 19th April 2024), Institutional Review Board, CHA Bundang Medical Center, CHA University (2024–03-006–003, 22th April 2024), Institutional Review Board, Hanyang University Guri Hospital (2024–02-022–002, 1th April 2024). The Ministry of Food and Drug Safety of Korea has approved the clinical trial and investigation device exemption (1699, 19th March 2024).
: Before the start of the clinical trial, the informed consent process included notifying participants that the information collected and the trial results may be published. It was also explained that confidentiality of personal information would be maintained in any publication of the trial results. Participants confirmed their understanding of all details and provided consent of their own free will.
: THP, CY, SL, and CC are employees of EverEx Inc., the sponsor of this study, and receive salaries from the company. JHP and CBC serves as an advisor but does not receive compensation from EverEx Inc.
